"Le Centre Oscar Lambret de Lille, situé dans la région des Hauts-de-France, est une référence nationale en cancérologie. Hôpital universitaire, il a trois missions principales: le soin, la recherche et l'enseignement. Le Centre Oscar Lambret, créé en 1955, fait partie du groupe UNICANCER, qui réunit les 18 Centres de Lutte Contre le Cancer, établissements de santé privés d’intérêt collectif (ESPIC) exclusivement dédiés aux soins, à la recherche et à l’enseignement en cancérologie, et participant au service public hospitalier avec des tarifs conventionnels, sans aucun dépassement d’honoraires. Le Centre a été certifié par la Haute Autorité de Santé en septembre 2018."

During the past decade, Centre Oscar Lambret conducted 278 clinical trials. In the 10-year time frame, 278 clinical trials started and 47 clinical trials were completed, i.e. on average, 16.9% percent of trials that started reached the finish line to date. In the past 5 years, 126 clinical trials started and 31 clinical trials were completed. i.e. 24.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Oscar Lambret" #1 sponsor was "Centre Oscar Lambret" with 107 trials, followed by "UNICANCER" with 72 trials sponsored, "Centre Leon Berard" with 33 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 21 trials sponsored and "ARCAGY/ GINECO GROUP" with 21 trials sponsored. Other sponsors include 256 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Oscar Lambret" #1 collaborator was "National Cancer Institute, France" with 33 trials as a collaborator, "AstraZeneca" with 14 trials as a collaborator, "Merck Sharp & Dohme LLC" with 13 trials as a collaborator, "Roche Pharma AG" with 11 trials as a collaborator and "Ministry of Health, France" with 9 trials as a collaborator. Other collaborators include 340 different institutions and companies that were collaborators in the rest 233 trials.

According to Clinical.Site data, the most researched conditions in "Centre Oscar Lambret" are "Breast Cancer" (65 trials), "Sarcoma" (16 trials), "Ovarian Cancer" (15 trials), "Colorectal Cancer" (14 trials) and "Head and Neck Cancer" (14 trials). Many other conditions were trialed in "Centre Oscar Lambret" in a lesser frequency.

Most popular intervention types in "Centre Oscar Lambret" are "Drug" (311 trials), "Procedure" (86 trials), "Other" (82 trials), "Radiation" (74 trials) and "Biological" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "fluorouracil" (19 trials), "radiation therapy" (18 trials), "cisplatin" (17 trials) and "Bevacizumab" (13 trials). Other intervention names were less common.

The vast majority of trials in "Centre Oscar Lambret" are 351 trials for "All" genders, 134 trials for "Female" genders and 25 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Oscar Lambret". 4 are not yet recruiting, 113 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 233 completed trials in Centre Oscar Lambret, 3 suspended trials, and 52 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Oscar Lambret, 51 "Phase 1" clinical trials were conducted, 189 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 107 trials that are defined as “Not Applicable".

Centre Oscar Lambret has several departments that took part in Clinical trials: "Centre Oscar Lambret; Senologie" - 7 trials, "Centre Oscar Lambret; Cancerologie Gynecologique" - 5 trials, "Centre Oscar Lambret; Service de Pediatrie" - 3 trials